The stain’s selectivity comes from the interaction between its copper phthalocyanine dye and myelin lipoproteins. In practice, this chemical affinity produces a blue signal that follows myelinated fibers more clearly than surrounding gray matter. That contrast supports structural mapping rather than merely coloring tissue visually.
Differentiation with lithium carbonate and ethanol is a control step that removes excess dye from gray matter while retaining the blue signal associated with myelin. This selective clearing increases contrast between white and gray matter, helping investigators distinguish genuine myelinated structures from nonspecific background in tissue sections.
Counterstains add cellular and tissue context around the myelin-specific signal. When used with Luxol Fast Blue, they support interpretation of neuronal tissue organization and neuropathological changes rather than replacing the primary stain. This combined view helps relate white-matter patterns to surrounding tissue architecture during microscopic assessment.
A practical workflow begins with applying the stain to neural tissue, followed by controlled differentiation using lithium carbonate and ethanol. Excess signal is removed from gray matter while myelin-associated blue remains. Researchers may then use counterstains to add organizational context for microscopic interpretation of the section.
Luxol Fast Blue is especially useful when the research question concerns white-matter anatomy, myelin integrity, or loss of myelinated tissue. In brain and spinal cord samples, staining can help map structures and reveal demyelination or white-matter loss. This makes it relevant to neuropathological studies, including investigations of multiple sclerosis.
Interpretation should focus on the distribution and preservation of the blue myelin-associated signal, not on color alone. Staining patterns can be considered alongside the tissue context revealed by counterstains. In this way, Luxol Fast Blue findings help distinguish organized white matter from patterns associated with demyelination or white-matter loss.